With respect to the diagnostic biomarkers, we detected significantly higher serum levels of CA125, HE4, IL-6, IL-8, G-CSF, SAA, MRP8/14, OPN, MMP9, and MMP2 in women with benign or malignant tumors than in healthy controls. This evidence concerns the gene S100A8 and cancer.